Supply of Omeprazole Extended-Release Capsules
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of 6,000 bottles of Omeprazole Extended-Release Capsules for prime contractors supporting DLA supply contracts. The medication must adhere to TYPE I (CODE M) non-extendable shelf life requirements of 24 months and be packaged and marked according to Medical Marking Standard No. 1. The contract requires the provider to hold all necessary pharmaceutical distribution licenses for prescription medication. Delivery is specified as FOB Destination, with the place of performance located in Weslaco, Texas. The solicitation was posted on September 24, 2026, with a response deadline of September 30, 2026, under NAICS code 423450.
General Info
Place of Performance
WESLACO, TX, 78596-0000, USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-5226.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
OMEPRAZOLE EXTENDED-RE
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
